AGN Allergan (AGN) Q4 results beat; on track to close AbbVie deal in Q1 6 years ago Allergan plc (NYSE: AGN), which is all set to be acquired by rival drugmaker AbbVie (ABBV), reported a 21% increase… Allergan (NYSE: AGN) Q3 loss widens but beats estimates 6 years ago Allergan plc (NYSE: AGN) reported a wider loss in the third quarter of 2019 due to the divestitures, products that… Allergan (AGN) Q3 earnings preview: Patent issues, AbbVie deal in focus 6 years ago After securing shareholders’ approval for the takeover deal with AbbVie (ABBV), Allergan (NYSE: AGN) will be publishing its third-quarter results…